IMCD acquires Tillmanns in Italy for €143 million

IMCD N.V. is set to acquire Tillmanns S.p.A., an Italian specialty chemicals distributor with €143 million in FY24 revenue, marking IMCD's largest deal since 2020 and adding 7% to group revenues. This strategic acquisition addresses investor concerns regarding a perceived slowdown in IMCD's M&A activity, particularly as the company's shares have declined 34% year-to-date and organic revenue growth has decelerated due to tariff impacts. The deal, expected to close in Q4 2025, will further strengthen IMCD's market presence in Italy.

Analysis

IMCD N.V. is re-engaging its merger and acquisition strategy with an agreement to acquire Italian specialty chemicals distributor Tillmanns S.p.A. for an undisclosed sum. This transaction is significant as it represents IMCD's largest deal since 2020, adding €143 million in revenue and contributing a 7% uplift to group revenues. The move directly addresses recent investor concerns about a perceived slowdown in M&A activity, a period which has coincided with significant stock underperformance; IMCD shares have declined 34% year-to-date, lagging both competitor Azelis (-30%) and the EuroStoxx index (+6%). This strategic acquisition occurs against a challenging operational backdrop, as the company's organic revenue growth has decelerated sharply from 4.2% in the first quarter of 2025 to just 0.7% in the second, a slowdown attributed to tariff uncertainties impacting industrial and personal care segments. While the deal strengthens IMCD's footprint in the Italian market, its financial impact is delayed, with closing not expected until the fourth quarter of 2025.

Key Decisions for Investors

• Investors should view the Tillmanns acquisition as a positive signal that management is reactivating its M&A playbook, potentially alleviating a key overhang on the stock.
• Caution is warranted due to the sharp deceleration in organic revenue growth, and it is crucial to monitor for stabilization in core volumes before becoming overly constructive on the fundamentals.
• Given the stock's 34% year-to-date decline, the current valuation may reflect recent operational headwinds, but any financial contribution from this acquisition is distant, with the deal not expected to close until late 2025.